Photo by nci from unsplash
Inflammation with leukocyte activation is a hallmark of cancer‐associated thrombosis (CAT), and elevated leukocytes predict venous thromboembolism in cancer outpatients. In a recent trial, rivaroxaban was more efficacious than dalteparin… Click to show full abstract
Inflammation with leukocyte activation is a hallmark of cancer‐associated thrombosis (CAT), and elevated leukocytes predict venous thromboembolism in cancer outpatients. In a recent trial, rivaroxaban was more efficacious than dalteparin in preventing CAT recurrence.
Keywords:
low molecular;
rivaroxaban;
anticoagulant activity;
activity low;
effect myeloperoxidase;
myeloperoxidase anticoagulant
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Thrombosis and Haemostasis
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!